We are live on
!
Find out more
TCM
Tetrem Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
16.55%
This Fund
S&P 500
This Quarter
Est. Return
+5.91%
1 Year Est. Return
+16.55%
3 Year Est. Return
+11.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.66B
AUM Growth
+$83.5M
(+3.2%)
Cap. Flow
-$44M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
38.46%
Holding
65
New
1
Increased
26
Reduced
31
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$33.5M |
| 2 |
Crown Castle
CCI
|
+$26.6M |
| 3 |
Eaton
ETN
|
+$22.9M |
| 4 |
Suncor Energy
SU
|
+$16.4M |
| 5 |
Royal Bank of Canada
RY
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$35.4M |
| 2 |
United Rentals
URI
|
+$32.5M |
| 3 |
Manulife Financial
MFC
|
+$23.5M |
| 4 |
McKesson
MCK
|
+$16.5M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.15% |
| 2 | Energy | 13.94% |
| 3 | Industrials | 11.3% |
| 4 | Healthcare | 11.04% |
| 5 | Communication Services | 7.47% |
Similar funds
HCM
AL
AT
RBC
DL
VKH
CAM
1GA
Tetrem Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Tetrem Capital Management held 65 positions worth $2.66B, up 3.2% from $2.58B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Tetrem Capital Management's Q3 2016 filing shows 1 new, 26 increased, 31 reduced and 4 closed positions. Its largest new stake was Gilead Sciences: 412,773 shares worth $32.7M. The largest sale was Teva Pharmaceuticals, an estimated $35.4M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 32% a quarter earlier, followed by Energy and Industrials.
- Tetrem Capital Management's largest Q3 2016 buy was Gilead Sciences: 412,773 shares worth $32.7M.
- Tetrem Capital Management added most to Crown Castle in Q3 2016, an estimated $26.6M increase.
- Tetrem Capital Management's biggest Q3 2016 reduction was Manulife Financial, cutting an estimated $23.5M.
- Tetrem Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $35.4M.
- Tetrem Capital Management's ten largest holdings make up 38% of its $2.66B portfolio in Q3 2016.
- Tetrem Capital Management opened 1 new position and closed 4 in Q3 2016.
- Tetrem Capital Management's portfolio value rose 3.2% quarter-over-quarter to $2.66B.
Based on Tetrem Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.